Caligan Partners LP's Net Worth

$627 Million

Estimate Recalculated Feb 22, 2024 05:13PM EST

Who is Caligan Partners LP?

Caligan Partners LP has an estimated net worth of $627 Million. This is based on reported shares across multiple companies, which include STANDARD BIOTOOLS INC., Liquidia Corp, AMAG PHARMACEUTICALS, INC., EXELIXIS, INC., and ALIMERA SCIENCES INC.

SEC CIK

Caligan Partners LP's CIK is 0001727492

Past Insider Trading and Trends

2022 was Caligan Partners LP's most active year for acquiring shares with 24 total transactions. Caligan Partners LP's most active month to acquire stocks was the month of April. 2023 was Caligan Partners LP's most active year for disposing of shares, totalling 6 transactions. Caligan Partners LP's most active month to dispose stocks was the month of July. 2023 saw Caligan Partners LP paying a total of $41,540,590.67 for 18,247,634 shares, this is the most they've acquired in one year. In 2023 Caligan Partners LP cashed out on 17,835,131 shares for a total of $4,564,848.49, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

STANDARD BIOTOOLS INC. (LAB) Snapshot price: $2.35

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-4.57%
-779.35K
16.27M
Jun 29 - Jul 3
Form 4
-25.06%
-2.87M
8.58M
Dec 29
Form 4
+1.35%
301.18K
$1.75
$526,608.41
22.63M
Aug 3 - Aug 4
Form 4
+2.93%
620.47K
$1.50
$953,649.68
21.8M
Jul 29 - Aug 2
Form 4
+0.96%
100K
$1.70
$170,000.00
10.52M
Jun 13
Form 4
+2.23%
450K
$1.95
$879,000.00
20.6M
Jun 2 - Jun 3
Form 4
+2.51%
488.35K
$2.71
$1,406,715.00
19.92M
May 6 - May 10
Form 4
+2.20%
400K
$2.55
$1,075,574.00
18.6M
Apr 28 - May 2
Form 4
+1.09%
195K
$3.74
$741,150.00
18.12M
Apr 11 - Apr 12
Form 4
+3.02%
509.57K
$3.71
$1,922,462.80
17.38M
Apr 6 - Apr 8
Form 3
0
0
No matching records found

Liquidia Corp (LQDA) Snapshot price: $14.565

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+10.99%
1.12M
$7.16
$7,999,996.88
11.28M
Dec 14
Form 4
0
0
Jun 19
Form 4
+2.41%
250K
$5.62
$1,405,000.00
10.64M
Sep 6
Form 4
+0.77%
79.4K
$3.40
$269,960.00
10.39M
May 25
Form 4
+1.09%
221.1K
$5.92
$1,301,472.56
20.47M
May 17 - May 19
Form 4
+21.19%
1.76M
$5.10
$8,999,995.50
10.09M
Apr 18
Form 3
0
0
No matching records found

AMAG PHARMACEUTICALS, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.50M
0
Nov 16
Form 3
0
0
No matching records found

EXELIXIS, INC. (EXEL) Snapshot price: $21.16

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+20.86%
190K
$20.70
$3,932,734.00
1.1M
Feb 21
Form 4
0
$21.61
910.73K
Nov 27
Form 4
18.18K
18.18K
May 31
Form 3
0
0
No matching records found

ALIMERA SCIENCES INC (ALIM) Snapshot price: $3.95

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
$3.39
33.09M
Sep 14
Form 4
+421.30%
16.36M
$1.90
$28,975,745.30
20.24M
Aug 15
Form 3
0
0
No matching records found